{"id":23939,"date":"2019-08-13T00:00:00","date_gmt":"2019-08-13T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2019\/08\/13\/doctors-say-new-drugs-cured-two-ebola-patients\/"},"modified":"2019-08-14T16:06:47","modified_gmt":"2019-08-14T16:06:47","slug":"doctors-say-new-drugs-cured-two-ebola-patients","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2019\/08\/13\/doctors-say-new-drugs-cured-two-ebola-patients\/","title":{"rendered":"Doctors Say New Drugs &#8216;Cured&#8217; Two Ebola Patients"},"content":{"rendered":"<h3>The two drugs &#8212; REGN-EB3 and mAb-114 &#8212; are monoclonal antibodies that block Ebola<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>TUESDAY, Aug. 13, 2019 (HealthDay News) &#8212; New drugs cured two Ebola patients in Congo, showing that people can recover from the highly lethal disease if it is diagnosed and treated early, doctors say.<\/p>\n<p>&#8220;These cases were detected very quickly. The husband was infected, he was at home for 10 days and his wife and son were infected,&#8221; Jean-Jacques Muyembe, M.D., Ph.D., director of Congo&#8217;s National Institute for Biomedical Research, said at a press conference, the <i>Associated Press<\/i> reported. &#8220;As soon as the response teams detected these cases, they brought them here to the treatment center. We gave them treatment that is effective and here in a short time both are cured.&#8221;<\/p>\n<p>The two drugs &#8212; REGN-EB3 and mAb-114 &#8212; are monoclonal antibodies that block Ebola and are now being &#8220;used to treat Ebola patients because, according to the studies and the results we obtained in the lab, these are the two drugs that are effective,&#8221; Muyembe said, the <i>AP<\/i> reported.<\/p>\n<p>Earlier this week, preliminary results from two trials in Congo suggested that the two drugs significantly reduced the risk for death from Ebola.<\/p>\n<p><a href=\"https:\/\/www.apnews.com\/82f4731e6fab47dc8c88c418834bd505\" target=\"_new\" rel=\"noopener noreferrer\"><i>AP News<\/i> Article<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2018 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The two drugs &#8212; REGN-EB3 and mAb-114 &#8212; are monoclonal antibodies that block Ebola<\/p>\n","protected":false},"author":6,"featured_media":23957,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-23939","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/23939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=23939"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/23939\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/23957"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=23939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=23939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=23939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}